THYROID FUNCTION DURING THE FIRST YEAR OF RECOMBINANT HUMAN GROWTH HORMONE THERAPY IN SHORT STATURE CHILDREN

Authors

  • Oana-Maria CAPRARU University of Medicine and Pharmacy, Târgu Mureș, Romania
  • Ionela M. PASCANU University of Medicine and Pharmacy, Târgu Mureș, Romania

Abstract

Introduction: The relationship between rhGH treatment and thyroid function has been the subject of numerous studies. Some say that rhGH treatment unmasks central hypothyroidism, other say that rhGH induces subclinical primary hypothyroidism. Aim: To assess the changes in thyroid function in short stature children in the first year of treatment with rhGH and the impact on growth velocity. Material and methods: We evaluated 37 patients treated with rhGH, 5 were excluded because developed side effects during treatment. We measured height, height velocity, and height standard deviation gain during treatment and thyroid function during the first year of treatment. Results: We observed a slight increase in the TSH level and no significant change in the f T4 level after the first 3-6 months of treatment in all the groups; in GH deficiency (GHD) patients, we observed a statistically significant decrease of the f T4 level after the first 3-6 months, without a significant increase of the TSH level. After the first year, thyroid function returned to baseline. There were no differences between height velocities in all the groups, except from the GHD patients. Conclusions: The slight increase in the TSH level and the decrease of f T4 level might unmask a transient subclinical primary hypothyroidism but these changes do not influence the growth velocity in first year of rhGH treatment.

Author Biographies

  • Oana-Maria CAPRARU, University of Medicine and Pharmacy, Târgu Mureș, Romania

    Faculty of Medicine
    Department of Physiology                                                                                                                                                          Ph.D. student

  • Ionela M. PASCANU, University of Medicine and Pharmacy, Târgu Mureș, Romania

    Faculty of Medicine
    Department of Physiology                                                                                                                                                Department of Endocrinology 

References

1. Brook C, Clayton P, Brown R. Brook’s Clinical Pediatric Endocrinology. Sixth Edition, Wiley-Blackwell, 2009.
2. Deal CL, Tony M, Höybye C, Allen DB, Tauber M and Christiansen JS. Growth Hormone research society workshop summary: Consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab 2013; 98(6): E1072-E1087.
3. Giavoli C, Porretti S, Ferrante E et al. Recombinant hGH replacement therapy and the hypothalamus–pituitary–thyroid axis in children with GH deficiency: when should we be concerned about the occur-rence of central hypothyroidism? Clin Endocrinol 2003; 59: 806–810.
4. Smyczynska J, Hilczer M, Stawerska R, Lewinski A.Thyroid function in children with growth hor-mone (GH) deficiency during the initial phase of GH replacement therapy - clinical implications. Thyroid Res 2010; 223(1): 2-6.
5. Richmond E, Rogol AD. Current indications for growth hormone therapy for children and adolescents. Endocrine Develop 2010, 18:92-108.
6. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford, California: Stanford University Press, 1993.
7. Ferreti I, Persani L, Jaffrain-Rea ML, Gimbona S, Tamnurrano G. Evaluation of adequacy of levothy-roxine replacement therapy in patients with central hypothyroidism. J Clin Endocrinol Metab 1999; 84: 924-929.
8. Portes S, Oliveira JHA, Maccagnan P and Abucham J. Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone (GH) replacement therapy in GH deficient chil-dren. Clin Endocrinol 2000; 53: 183-189.
9. Seminara S, Stagi S, Candura L et al. Changes of thyroid function during long-term hGH therapy in GHD children. A possbile relationship with catch-up growth? Horm Metab Res 2005; 37: 751-756.
10. El-Mansoury M, Bryman I, Berntorp K, Hanson Ch, Wilhelmsen L, Landin-Wilhelmsen. K Hypothy-roidism Is Common in Turner Syndrome: Results of a Five-Year Follow-Up. J Clin Endocrinol Metab 2005; 90(4): 2131–2135.
11. Jorgensen JO, Moller J, Laursen T, Orskov H, Christiansen JS, Weeke J: Growth hormone admin-istration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and supresses circadian throtrophin levels: studies in GH-deficient adults. Clin Endocrinol (Oxf) 1994; 41: 609-614.
12. Wyatt DT, Gesundheit N, Sherman B. Changes in Thyroid hormone levels during Growth Hormone therapy in initially euthyroid patients: lack of need for thyroxine supplementation; J Clin Endocrinol Metab 1998: 83(10): 3493-3497.
13. Kalina-Faska B, Kalina M, Koehler B. Assessement of thyrotropin concentrations in children with somatotropin deficiency treated with growth hormone. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2002; 8: 17-21.

Additional Files

Published

2018-05-02

Issue

Vol. 118 No. 2 (2014): The Medical-Surgical Journal

Section

INTERNAL MEDICINE - PEDIATRICS

License

COPYRIGHT 
Once an article is accepted for publication, MSJ requests a transfer of copyrights for published articles.

COPYRIGHT TRANSFER FORM FOR 

REVISTA MEDICO-CHIRURGICALĂ A SOCIETĂȚII DE MEDICI ȘI NATURALIȘTI DIN IAȘI /

THE MEDICAL-SURGICAL JOURNAL OF THE SOCIETY OF PHYSICIANS AND NATURALISTS FROM IASI

We, the undersigned authors of the manuscript entitled

_____________________________________________________________________________________

_____________________________________________________________________________________

warrant that this manuscript, which is submitted for publication in the REVISTA MEDICO-CHIRURGICALĂ, has not been published and it is not under consideration for publication in another journal.

  1. we give the consent for publication in the REVISTA MEDICO-CHIRURGICALĂ, in printed and electronic format and we transfer unconditioned and complete the copyright of this manuscript to the REVISTA MEDICO-CHIRURGICALĂ, in the event of its acceptance.
  2. the manuscript does not break the intellectual property rights of any other person.
  3. we have read the submitted version of the manuscript and we are fully responsible for the content.

Names and signatures of authors / copyright owners (the following sequence is the authorship of the article):

  1. ______________________________/_________________________
  2. ______________________________/_________________________
  3. ______________________________/_________________________

N.B.  All the authors must sign this form